Safety and efficacy of low-dose Iloprost administration in addition to standard therapy, as compared to standard therapy alone, in post-cardiac- arrest-syndrome patients – a randomized, controlled, double-blinded investigator-initiated trial

Trial Profile

Safety and efficacy of low-dose Iloprost administration in addition to standard therapy, as compared to standard therapy alone, in post-cardiac- arrest-syndrome patients – a randomized, controlled, double-blinded investigator-initiated trial

Completed
Phase of Trial: Phase II

Latest Information Update: 22 Jun 2017

At a glance

  • Drugs Iloprost (Primary)
  • Indications Heart arrest
  • Focus Pharmacodynamics
  • Acronyms ENDO-RCA
  • Most Recent Events

    • 21 Jun 2017 Status changed from recruiting to completed.
    • 13 Jan 2015 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top